Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Galantamine in Tic Disorders

This study has been terminated.
(Unable to recruit subjects into the trial.)
Sponsor:
Collaborator:
Ortho-McNeil Neurologics, Inc.
Information provided by:
Parkinson's Disease and Movement Disorders Center
ClinicalTrials.gov Identifier:
NCT00226824
First received: September 23, 2005
Last updated: August 21, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given